Loading…

The inflammatory cytokine, GM‐CSF, alters the developmental outcome of murine dendritic cells

Fms‐like tyrosine kinase 3 ligand (Flt3L) is a major cytokine that drives development of dendritic cells (DCs) under steady state, whereas GM‐CSF becomes a prominent influence on differentiation during inflammation. The influence GM‐CSF exerts on Flt3L‐induced DC development has not been thoroughly...

Full description

Saved in:
Bibliographic Details
Published in:European journal of immunology 2012-11, Vol.42 (11), p.2889-2900
Main Authors: Zhan, Yifan, Vega‐Ramos, Javier, Carrington, Emma M., Villadangos, Jose A., Lew, Andrew M., Xu, Yuekang
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Fms‐like tyrosine kinase 3 ligand (Flt3L) is a major cytokine that drives development of dendritic cells (DCs) under steady state, whereas GM‐CSF becomes a prominent influence on differentiation during inflammation. The influence GM‐CSF exerts on Flt3L‐induced DC development has not been thoroughly examined. Here, we report that GM‐CSF alters Flt3L‐induced DC development. When BM cells were cultured with both Flt3L and GM‐CSF, few CD8+ equivalent DCs or plasmacytoid DCs developed compared to cultures supplemented with Flt3L alone. The disappearance of these two cell subsets in GM‐CSF + Flt3L culture was not a result of simple inhibition of their development, but a diversion of the original differentiation trajectory to form a new cell population. As a consequence, both DC progeny and their functions were altered. The effect of GM‐CSF on DC subset development was confirmed in vivo. First, the CD8+ DC numbers were increased under GM‐CSF deficiency (when either GM‐CSF or its receptor was ablated). Second, this population was decreased under GM‐CSF hyperexpression (by transgenesis or by Listeria infection). Our finding that GM‐CSF dominantly changes the regulation of DC development in vitro and in vivo has important implications for inflammatory diseases or GM‐CSF therapy.
ISSN:0014-2980
1521-4141
DOI:10.1002/eji.201242477